Robotic IV compounding comes to UMass

Hazardous IV prep is becoming an automated process at the UMass Memorial Medical Center in Massachusetts. The hospital is using the CytoCare robot from healthcare services provider and drug wholesaler McKesson to automate the compounding of intravenous drugs.

The robotic system lessons staff exposure to toxic agents in the hospital pharmacy, which handles about 5,000 IV products per month. That compounding load was spread across 11 pharmacists, says a release.

CytoCare boasts HL7 interfaces. And it has a continuous production flow feature that aids in planning sterile-prep schedules and in complying with quality and safety regulations.

- see the UMass release
- here's a video

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.